Predictive 5-year survivorship model of cystic fibrosis
- PMID: 11207152
- PMCID: PMC2198936
- DOI: 10.1093/aje/153.4.345
Predictive 5-year survivorship model of cystic fibrosis
Abstract
The objective of this study was to create a 5-year survivorship model to identify key clinical features of cystic fibrosis. Such a model could help researchers and clinicians to evaluate therapies, improve the design of prospective studies, monitor practice patterns, counsel individual patients, and determine the best candidates for lung transplantation. The authors used information from the Cystic Fibrosis Foundation Patient Registry (CFFPR), which has collected longitudinal data on approximately 90% of cystic fibrosis patients diagnosed in the United States since 1986. They developed multivariate logistic regression models by using data on 5,820 patients randomly selected from 11,630 in the CFFPR in 1993. Models were tested for goodness of fit and were validated for the remaining 5,810 patients for 1993. The validated 5-year survivorship model included age, forced expiratory volume in 1 second as a percentage of predicted normal, gender, weight-for-age z score, pancreatic sufficiency, diabetes mellitus, Staphylococcus aureus infection, Burkerholderia cepacia infection, and annual number of acute pulmonary exacerbations. The model provides insights into the complex nature of cystic fibrosis and supplies a rigorous tool for clinical practice and research.
Figures

Similar articles
-
Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.Lancet Respir Med. 2019 Dec;7(12):1027-1038. doi: 10.1016/S2213-2600(19)30365-0. Epub 2019 Nov 11. Lancet Respir Med. 2019. PMID: 31727592 Free PMC article.
-
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.Lancet Respir Med. 2016 Aug;4(8):636-645. doi: 10.1016/S2213-2600(16)30105-9. Epub 2016 Jun 10. Lancet Respir Med. 2016. PMID: 27298019 Free PMC article.
-
Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.BMC Med Res Methodol. 2019 Apr 26;19(1):88. doi: 10.1186/s12874-019-0705-0. BMC Med Res Methodol. 2019. PMID: 31027503 Free PMC article.
-
Oscillating devices for airway clearance in people with cystic fibrosis.Cochrane Database Syst Rev. 2020 Apr 30;4(4):CD006842. doi: 10.1002/14651858.CD006842.pub5. Cochrane Database Syst Rev. 2020. PMID: 32352564 Free PMC article.
-
Omega-3 fatty acid supplementation for cystic fibrosis.Cochrane Database Syst Rev. 2020 Apr 10;4(4):CD002201. doi: 10.1002/14651858.CD002201.pub6. Cochrane Database Syst Rev. 2020. PMID: 32275788 Free PMC article.
Cited by
-
Survival models to support shared decision-making about advance care planning for people with advanced stage cystic fibrosis.BMJ Open Respir Res. 2021 May;8(1):e000794. doi: 10.1136/bmjresp-2020-000794. BMJ Open Respir Res. 2021. PMID: 34031106 Free PMC article.
-
Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis.J Cyst Fibros. 2016 Nov;15(6):783-790. doi: 10.1016/j.jcf.2016.04.005. Epub 2016 Apr 29. J Cyst Fibros. 2016. PMID: 27139161 Free PMC article.
-
Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.PLoS One. 2013 Apr 30;8(4):e62917. doi: 10.1371/journal.pone.0062917. Print 2013. PLoS One. 2013. PMID: 23646159 Free PMC article.
-
Cystic Fibrosis: Microbiology and Host Response.Pediatr Clin North Am. 2016 Aug;63(4):617-36. doi: 10.1016/j.pcl.2016.04.003. Pediatr Clin North Am. 2016. PMID: 27469179 Free PMC article. Review.
-
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.Pediatr Pulmonol. 2013 Jul;48(7):666-73. doi: 10.1002/ppul.22652. Epub 2012 Aug 8. Pediatr Pulmonol. 2013. PMID: 22888106 Free PMC article.
References
-
- Anderson DH. Cystic fibrosis of the pancreas and its relation to celiac disease. A clinical and pathologic study. Am J Dis Child. 1938;56:344–95.
-
- Farber S. Some organic digestive disturbances in early life. J Michigan Med Sci. 1945;44:587–94.
-
- Cystic Fibrosis Foundation Patient Registry annual data report, 1998. Bethesda, MD; Cystic Fibrosis Foundation: 1999.
-
- Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984;104:206–10. - PubMed
-
- Thomassen MJ, Demko CA, Klinger JD, et al. Pseudomonas cepacia colonization among patients with cystic fibrosis. Am Rev Respir Dis. 1985;131:791–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical